Retirement of independent non-executive director – Peter Hinton
Appointment of new independent non-executive director – Pip Greenwood
The a2 Milk Company Limited advises that Peter Hinton will be retiring from the Board at the end of the financial year on 30 June, as foreshadowed at the Company’s 2018 Annual Meeting.
David Hearn, Chair of the Board, said of Peter’s retirement, “We would like to thank Peter for his exceptional and longstanding commitment to the a2 Milk™ business, originally as advisor to and partner of Dr Corran McLachlan, the Company’s founder, and subsequently as an adviser and director of the Company. We wish Peter all the best as he pursues interests outside of The a2 Milk Company and corporate governance roles.”
The Company is pleased to advise that Pip Greenwood will be appointed as an independent non-executive director of the Company with effect from 1 July 2019.
Pip is a director on the boards of Westpac New Zealand, Spark New Zealand and Fisher & Paykel Healthcare. She was previously a senior partner at law firm Russell McVeagh, where she spent over ten years on the firm’s board including acting as the firm’s board Chair and interim CEO. A leader in the field of corporate law and in the New Zealand business community, Pip is also known for her work promoting greater diversity in the workplace. She is the recipient of numerous industry awards including last year being named New Zealand Dealmaker of the Year at the Australasian Law Awards 2018, the only person to have won this accolade five times, and has twice been recognised as a finalist at the Women of Influence Awards.
David Hearn said of Pip’s appointment, “We are delighted to have a person of Pip’s considerable talent and experience join the Board.”
The Board has determined that Ms Greenwood will be an independent director. A resolution to elect Ms Greenwood will be put to shareholders at the Company’s next annual meeting in November 2019.
The a2 Milk Company Limited
A PDF of this announcement may be found here.
For further information, please contact:
Investors / Analysts
Head of Investor Relations
T +61 2 9697 7013 l M +61 412 944 577